Prevention of breast cancer using rexinoids: results of a phase II biomarker modulation trial using bexarotene in women at high risk of breast cancer.

被引：0
|
作者：
Brown, P. [1 ,2 ,3 ,4 ,5 ,6 ]
Arun, B. [1 ,2 ,3 ,4 ,5 ,6 ]
Miller, A. [1 ,2 ,3 ,4 ,5 ,6 ]
Isaacs, C. [1 ,2 ,3 ,4 ,5 ,6 ]
Gutierrez, C. [1 ,2 ,3 ,4 ,5 ,6 ]
Huang, J. [1 ,2 ,3 ,4 ,5 ,6 ]
Mohsin, S. [1 ,2 ,3 ,4 ,5 ,6 ]
Sneige, N. [1 ,2 ,3 ,4 ,5 ,6 ]
Kim, H. [1 ,2 ,3 ,4 ,5 ,6 ]
Sexton, K. [1 ,2 ,3 ,4 ,5 ,6 ]
Weiss, H. [1 ,2 ,3 ,4 ,5 ,6 ]
Hilsenbeck, S. [1 ,2 ,3 ,4 ,5 ,6 ]
Lamph, W. [1 ,2 ,3 ,4 ,5 ,6 ]
Negro-Vilar, A. [1 ,2 ,3 ,4 ,5 ,6 ]
Johnson, K. [1 ,2 ,3 ,4 ,5 ,6 ]
Elledge, R. [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] MD Anderson Canc Ctr, Houston, TX USA
[3] Canc Therapy & Res Ctr S Texas, San Antonio, TX 78229 USA
[4] Georgetown Univ, Washington, DC USA
[5] Ligand Pharmaceut, San Diego, CA USA
[6] Natl Canc Inst, Bethesda, MD USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S181 / S182
页数：2
相关论文
共 50 条
  • [21] Diagnosis and prevention of breast cancer in women at high risk
    Wood, W.
    CANCER RESEARCH, 2009, 69 (02) : 63S - 63S
  • [22] Effect of risk communication on anxiety, breast cancer worry and risk perception in women at high risk of breast cancer.
    Xie, Zhuoer
    Wenger, Neil
    Johansen, Liliana
    Elashoff, David
    Trent, Jacqueline
    Lee, Kristina
    Kaplan, Celia
    Madlensky, Lisa
    Layton, Tracy M.
    Petruse, Antonia
    Naeim, Arash
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] Breast cancer prevention in high-risk women
    Thorat, Mangesh A.
    Balasubramanian, Rajeshkumar
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2020, 65 : 18 - 31
  • [24] Breast cancer risk perception among relatives of women with breast cancer.
    Gilligan, M
    Schapira, M
    Lu, N
    Boudreau, C
    Nattinger, AB
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 : 76 - 76
  • [25] Predictors of use of prevention strategies among women at high-risk for breast cancer.
    Landry, Kara
    Tuo, Ya
    Levine, Emma
    Srikureja, Anya
    Wood, Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [26] Prevention of breast cancer with rexinoids: Preclinical and early phase clinical studies.
    Brown, P
    Wu, K
    Mohsin, S
    Hilsenbeck, SG
    Lamph, W
    Johnson, K
    Elledge, R
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1952S - 1952S
  • [27] Breast cancer screening in women at high risk using MRI
    Leach, Martin O.
    NMR IN BIOMEDICINE, 2009, 22 (01) : 17 - 27
  • [28] A short-term biomarker modulation prevention study of simvastatin in women at increased risk for breast cancer
    Higgins, M. J.
    Prowell, T. M.
    Blackford, A.
    Slater, S.
    Argani, P.
    Green, H.
    Khouri, N.
    Blumenthal, R.
    Garber, J. E.
    Stearns, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] A short-term biomarker modulation prevention study of anastrazole in women at increased risk for breast cancer
    Arun, B.
    Valero, V.
    Brewster, A.
    Gutierrez, A.
    Green, M.
    Esteva, F.
    Buzdar, A.
    Hortobagyi, G. N.
    Sneige, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] Breast cancer.: Update in risk factors and prevention
    Soler Lopez, Jordi
    Cases, Ana B.
    Checa, Miguel A.
    del Mar Vernet, Maria
    Carreras, Ramon
    GINECOLOGIA Y OBSTETRICIA CLINICA, 2007, 8 (01): : 29 - 36
12345